NLS Pharmaceutics Ltd. Warrant
NLSPW
NLSPW
5 hedge funds and large institutions have $261K invested in NLS Pharmaceutics Ltd. Warrant in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
-3
Holders Change %
-37.5%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
2
Calls
$240K
Puts
–
Net Calls
+$240K
Net Calls Change
+$191K
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
ACM
1
AIGH Capital Management
Baltimore,
Maryland
|
$0 |
| 2 |
WVP
2
Worth Venture Partners
Fort Lee,
New Jersey
|
$0 |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$1.09K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $145K | – | – | – |
|
|
AC
2
Ayrton Capital
Westport,
Connecticut
| $49.3K | – | – | – |
|
|
ACM
3
Altium Capital Management
New York
| $38K | – | – | – |
|
4
Hudson Bay Capital Management
Stamford,
Connecticut
| $27.7K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $1.09K | -$3.42K | -11,802 | -76% |
|
|
ACM
6
AIGH Capital Management
Baltimore,
Maryland
| – | -$158K | -633,361 | Closed |
|
|
WVP
7
Worth Venture Partners
Fort Lee,
New Jersey
| – | -$49K | -194,060 | Closed |
|